Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative Analysis
Chiyuan Zhang, Cuishan Guo, Yan Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial
Andréas Mackensen, John B.A.G. Haanen, Christian Koenecke, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2844-2853
Open Access | Times Cited: 114
Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests
Tiago Brito‐Rocha, Vera Constâncio, Rui Henrique, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 935-935
Open Access | Times Cited: 51
Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer
Ying Yu, Xing Huang, Chaoqi Liang, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 176007-176007
Closed Access | Times Cited: 51
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
Christiane Stadler, Ursula Ellinghaus, Leyla Fischer, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 748
Open Access | Times Cited: 10
The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis
Adrian Georg Simon, Su Ir Lyu, Mark Laible, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors
Giuseppe Schepisi, Caterina Gianni, Maria Concetta Cursano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer
Junping Li, Hong Hu, Hui Lian, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1578-1601
Open Access | Times Cited: 4
CLDN6: From Traditional Barrier Function to Emerging Roles in Cancers
Huinan Qu, Jin Qiu, Chengshi Quan
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13416-13416
Open Access | Times Cited: 26
Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer
Jing Yuan, Hua Lan, Dongqing Huang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 19
177Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Huan Du, Xiaofei Hao, Binwei Lin, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268487-jnumed.124.268487
Open Access
Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune infiltration
Xinyue Shi, Jingyu Zang, Qi Gu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The Chimeric Antigen Receptor T Cell Target Claudin 6 Is a Marker for Early Organ-Specific Epithelial Progenitors and Is Expressed in Some Pediatric Solid Tumor Entities
Larissa Seidmann, Arthur Wingerter, Marie Oliver Metzig, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 920-920
Open Access
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges
Hinrich Abken
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarker
Ping Yang, Jiayu Yin, Gongyin Zhang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma
Sahand Saeidpour Masouleh, Kamyar Nasiri, Ava Ostovar Ravari, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines
Kiavash Hushmandi, Abbas Ali Imani Fooladi, Rüssel J. Reiter, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
p38 MAPK–mediated upregulation of claudin-3 and claudin-4 by gemcitabine contributes to chemoresistance in ovarian cancer
Jiaxin Zhao, Jia Ke, Xiaochao Cao, et al.
The International Journal of Biochemistry & Cell Biology (2025) Vol. 185, pp. 106805-106805
Closed Access
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
Margaretha A. Skowron, Mara Kotthoff, Felix Bremmer, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer
Chun‐Mei Hu, Min Liu, Yutao Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Aberrant expression of cuproptosis‑related gene LIPT1 is associated with metabolic dysregulation of fatty acid and prognosis in hepatocellular carcinoma
Jin‐Ping Li, Dayun Tuo, Gunan Guo, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 15763-15779
Closed Access | Times Cited: 9
Applications of Flow Cytometry in Drug Discovery and Translational Research
Sumana Ullas, Charles Sinclair
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3851-3851
Open Access | Times Cited: 3
Novel therapeutics in refractory germ cell tumors
Noah Richardson, Nabil Adra
Current Opinion in Oncology (2025)
Closed Access
High-Frequency Irreversible Electroporation (H-FIRE) Induced Blood–Brain Barrier Disruption Is Mediated by Cytoskeletal Remodeling and Changes in Tight Junction Protein Regulation
Brittanie Partridge, Yukitaka Kani, Melvin F. Lorenzo, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1384-1384
Open Access | Times Cited: 12
Vaccine Boosting CAR-T Cell Therapy: Current and Future Strategies
Emmanuel Owusu Ansah, Andy Baah, Emmanuel Boateng Agyenim
Advances in Cell and Gene Therapy (2023) Vol. 2023, pp. 1-9
Open Access | Times Cited: 7
Independent prognostic value of CLDN6 in bladder cancer based on M2 macrophages related signature
Da Qi, Yan Lu, Huinan Qu, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109138-109138
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top